Wockhardt is currently trading at Rs. 255.15, up by 0.75 points or 0.29% from its previous closing of Rs. 254.40 on the BSE.
The scrip opened at Rs. 257.50 and has touched a high and low of Rs. 260.70 and Rs. 247.80 respectively. So far 54891 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 691.30 on 17-Sep-2018 and a 52 week low of Rs. 247.80 on 23-Aug-2019.
Last one week high and low of the scrip stood at Rs. 287.70 and Rs. 247.80 respectively. The current market cap of the company is Rs. 2828.51 crore.
The promoters holding in the company stood at 74.06%, while Institutions and Non-Institutions held 6.01% and 19.93% respectively.
Wockhardt has received GMP Compliance Certificate from French National Agency for Medicines and Health Products Safety for its manufacturing Unit at Ankleshwar, Gujarat. The manufacturing facility complies with the principles of Good Manufacturing Practices for active substances.
This is reflected in the Eudra GMDP database. The said GMP Compliance Certificate is valid for a period of 3 years i.e. upto April 2, 2022. EudraGMDP is the name of the European Union database which inter-alia contains Good Manufacturing (GMP) Certificates.
Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.